IVIM-DWI MRI评估rhES诱导结直肠癌小鼠肿瘤血管正常化
该研究建立BALB/c小鼠CT26结直肠癌移植瘤模型,比较rhES组与对照组的IVIM-DWI参数与免疫荧光指标。结果显示D(*)和f与MVD、周细胞覆盖率及肿瘤灌注相关,可监测血管正常化时间窗。
要点
- IVIM-DWI参数D(*)和f可无创评估rhES诱导的肿瘤血管正常化。
- D(*)与f分别与MVD、周细胞覆盖率和肿瘤灌注显著相关。
- D(*)和f的动态变化可监测血管正常化时间窗。
核心结论
- IVIM-DWI MRI可有效评估rhES诱导的CT26结直肠癌血管正常化,D(*)和f与MVD、周细胞覆盖率和肿瘤灌注密切相关,能监测血管正常化时间窗。
研究设计与样本
- 建立BALB/c小鼠CT26结直肠癌移植瘤模型,分为rhES组和对照组,每组20只。
- rhES组静脉注射rhES 5 mg·kg(-1)·d(-1),1次/d,连用12 d;对照组注射同体积0.9%生理盐水。
- 干预前及干预后第4、8、12天每组随机选5只小鼠行IVIM-DWI MRI,并检测MVD、周细胞覆盖率和肿瘤灌注。
主要发现
- 干预前两组肿瘤体积差异无统计学意义(P=0.440);干预后第2至12天rhES组肿瘤体积始终低于对照组(均P<0.05)。
- rhES组第4天和第8天D(*)值分别为(10.940±2.834)×10(-3)mm(2)/s和(12.940±2.801)×10(-3)mm(2)/s,高于对照组(6.980±1.554)×10(-3)mm(2)/s和(7.898±1.603)×10(-3)mm(2)/s(均P<0.05);第12天D(*)值为(6.848±1.460)×10(-3)mm(2)/s,低于对照组(9.950±2.596)×10(-3)mm(2)/s(P<0.05)。
- rhES组第8天f值为(0.226±0.021)%,高于对照组(0.178±0.016)%(P<0.01)。
- 第4天和第8天rhES组MVD低于对照组(P<0.05),周细胞覆盖率和肿瘤灌注高于对照组(均P<0.05)。
- rhES组D(*)与MVD、周细胞覆盖率、肿瘤灌注相关(r=-0.354、0.555、0.559,均P<0.05);f亦相关(r=-0.391、0.538、0.315,均P<0.05)。
临床怎么用
- 在rhES抗血管生成治疗中,可用IVIM-DWI的D(*)和f动态监测血管正常化时间窗,辅助优化治疗联合时序。
局限性
- 研究为小鼠移植瘤模型,样本量有限,结论需临床验证。
- MRI与病理指标为短期动态观察,未涉及长期疗效或生存终点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the feasibility of intravoxel incoherent motion diffusion-weighted magnetic resonance imaging (IVIM-DWI MRI) in the evaluation of tumor vascular normalization in a mouse model of colorectal cancer induced by recombinant human endostatin (rhES). Methods: The CT26 colorectal cancer xenograft model of BALB/c mice were established and divided into rhES group and control group, with 20 mice in each group. The mice of rhES group were intravenously injected with rhES 5 mg·kg(-1)·d(-1) once daily for 12 days, while the mice of the control group were intravenously injected with the same volume of 0.9% saline. 5 mice of rhES group and control group were randomly selected to perform IVIM-DWI MRI as following times: before treatment and four, eight, twelve days after treatment. The parameters of IVIM-DWI were recorded, including true diffusion coefficient(D), pseudo-diffusion coefficient (D(*)) and perfusion fraction (f). Meanwhile, microvessel density (MVD), pericyte coverage and tumor perfusion in tumor tissues were detected by immunofluorescence, respectively. Results: The tumor volumes of control group and rhES group before treatment were (154.42±24.65) mm(3) and (174.24±28.27)mm(3,) respectively, without statistically significant difference (P=0.440). From day 2 to day 12 after treatment, the tumor volume of rhES group was significantly smaller than that of control group (all P<0.05). There were no statistical significances of D value between the rhES group and control group before and after treatment (all P>0.05). The D(*) values of the rhES group were (10.940±2.834)×10(-3)mm(2)/s and (12.940±2.801)×10(-3)mm(2)/s in day 4 and 8 after treatment respectively, significantly higher than (6.980±1.554)×10(-3)mm(2)/s and (7.898±1.603)×10(-3)mm(2)/s of control group (P<0.05). Moreover, compared with control group, the D(*) value of rhES group was significantly lower in day 12 (6.848±1.460)×10(-3)mm(2)/s vs (9.950±2.596)×10(-3)mm(2)/s, (P<0.05). The f value of rhES group in day 8 was (0.226±0.021)%, significantly higher than (0.178±0.016)% of control group (P<0.01). The MVD of rhES group was significantly lower than that of control group (P<0.05), while the pericyte coverage and tumor perfusion of rhES group were significantly higher than those of control group in day 4 and 8 after treatment (all P<0.05). In addition, we found D(*) value of IVIM-DWI in rhES group was significantly related with MVD, pericyte coverage and tumor perfusion (r=-0.354, r=0.555, r=0.559, all P<0.05). Meanwhile, the f value in rhES group was also significantly related with MVD, pericyte coverage and tumor perfusion (r=-0.391, r=0.538, r=0.315, all P<0.05). Conclusions: IVIM-DWI MRI can effectively evaluate the vascular normalization in rhES-induced CT26 colorectal tumor.The parameters D(*) and f are closely related to intratumorally microvessel density, pericyte coverage and perfusion, which can effectively monitor the occurrence of tumor vascular normalization time. 目的: 探讨体素内不相干运动扩散加权磁共振成像(IVIM-DWI MRI)评价重组人血管内皮抑素(rhES)诱导的结直肠癌小鼠模型肿瘤血管正常化的可行性。 方法: 建立BALB/c小鼠CT26结直肠癌移植瘤模型,分为rhES组和对照组,每组20只。rhES组静脉注射rhES 5 mg·kg(-1)·d(-1),1次/d,连用12 d;对照组静脉注射同体积生理盐水。rhES组和对照组分别在干预前和干预后第4天、第8天和第12天随机选取5只小鼠进行磁共振扫描,得到IVIM-DWI相关参数[真弥散系数(D)、伪弥散系数(D(*))和灌注分数(f)],以免疫荧光法检测微血管密度(MVD)、周细胞覆盖率和肿瘤内灌注情况。 结果: 干预前,对照组小鼠的肿瘤体积为(154.42±24.65)mm(3),rhES组小鼠的肿瘤体积为(174.24±28.27)mm(3),差异无统计学意义(P=0.440)。干预后第2天至第12天,对照组和rhES组小鼠的肿瘤体积均呈持续性增长趋势,但rhES组小鼠的肿瘤体积始终明显低于对照组(均P<0.05)。rhES组和对照组的D值在各时间点的差异均无统计学意义(均P>0.05)。rhES组干预后第4天和第8天的D(*)值分别为(10.940±2.834)×10(-3) mm(2)/s和(12.940±2.801)×10(-3) mm(2)/s,较对照组[分别为(6.980±1.554)×10(-3) mm(2)/s和(7.898±1.603)×10(-3) mm(2)/s]明显增高(均P<0.05)。但rhES组干预后第12天的D(*)值为(6.848±1.460)×10(-3) mm(2)/s,较对照组[(9.950±2.596)×10(-3) mm(2)/s]明显降低(P<0.05)。rhES组干预后第8天的f值为(0.226±0.021)%,明显高于对照组[(0.178±0.016)%,P<0.01]。干预后第4天和第8天,rhES组小鼠瘤体微血管密度(MVD)较对照组明显降低(P<0.05),而周细胞覆盖率和肿瘤内灌注率较对照组明显升高(均P<0.05)。rhES组D(*)值与MVD、周细胞覆盖率和肿瘤内灌注率均明显相关(r值分别为-0.354、0.555和0.559,均P<0.05),f值与MVD、周细胞覆盖率和肿瘤内灌注率亦明显相关(r值分别为-0.391、0.538和0.315,均P<0.05)。 结论: IVIM-DWI MRI可有效评估rhES诱导的CT26结直肠癌血管正常化,其参数D(*)、f与肿瘤内MVD、周细胞覆盖率和肿瘤内灌注率密切相关,能有效监测肿瘤血管正常化时间窗的发生。.
引用
- Zhu SB, Huang JL, Pan JH, et al. [Evaluation of tumor vascular normalization in colorectal cancer mouse mode induced by recombinant human endostatin by intravoxel incoherent motion diffusion-weighted magnetic resonance imaging]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31216827. doi:10.3760/cma.j.issn.0253-3766.2019.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。